The Beauty Tech Group plc

The Beauty Tech Group plc operates globally as a specialist in at-home beauty technology, with its offerings reaching consumers in the United States, Canada, the United Kingdom, the European Union, and Asia. The company handles the full lifecycle of its products, from development and manufacturing to direct retail of personal beauty devices. Its portfolio features devices harnessing advanced techniques like LED light, radiofrequency (RF), microcurrent, and laser therapies. Under the CurrentBody Skin brand, it markets LED light therapy and RF technology products directly to consumers via online channels. The ZIIP Beauty brand further expands its offerings with skincare formulations and innovative facial toning devices. Additionally, the Tria Laser brand specializes in at-home laser hair removal solutions. Founded in 2009, this Macclesfield, United Kingdom-based company was previously named Lunessa plc, adopting its current identity, The Beauty Tech Group plc, in September 2025.

The Beauty Tech Group plc trades as TBTG.L on LSE. The company is classified in Consumer Defensive / Household & Personal Products and reports in GBP.

The current profile places the business in Household & Personal Products. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £101.12M of revenue and £1.75M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

The Beauty Tech Group plc can be compared against peers such as Anpario plc, Camellia Plc, Cake Box Holdings Plc, Creightons Plc, Kitwave Group plc, McBride plc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £394.10M, beta of 1.56, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

TBTG.L currently shows total debt of N/A and beta of 1.56. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.thebeautytechgroup.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.